Search

everythinglearnresearchcommunity

for

Search:↓

Finasteride and dutasteride effectively treat hair loss, with dutasteride showing slightly better results.

Finasteride and dutasteride effectively treat hair loss, with dutasteride showing slightly better results.

5ARI treatment improves PSA test accuracy for prostate cancer diagnosis.

Tamoxifen may cause female hair loss by increasing androgen receptor expression.

Using 5-alpha reductase inhibitors may lower the risk of breast cancer in females.

The combination of oral minoxidil, oral dutasteride, and mesotherapy is the most effective and safe for hair growth in AGA.

Patients with advanced breast cancer prioritize quality of life, overall survival, and progression-free survival in treatment decisions.

A postmenopausal woman's hormone imbalance and symptoms improved after removing benign ovarian tumors.

Men taking 5-alpha-reductase inhibitors before or after bladder cancer diagnosis had a lower risk of dying from the disease.

Dutasteride mesotherapy for hair loss can cause lasting bald patches.

Testosterone therapy can help improve sexual function, mood, and bone density in women with low androgen levels, but more research is needed on long-term safety.

Auranofin shows promise as a cancer treatment, especially when combined with other therapies.

5ARIs effectively treat and manage BPH by reducing prostate size and symptoms.

IMTA can help regrow hair in severe alopecia areata when JAK inhibitors don't work well.

Epirubicin and cyclophosphamide cause more anemia and side effects than docetaxel and cyclophosphamide, but both are equally effective.

Chemotherapy with carboplatin-paclitaxel causes hair loss in all patients.

Subcutaneous trastuzumab improves some symptoms and doesn't harm overall quality of life in breast cancer patients.

The treatment effectively reduces menopausal symptoms and is well tolerated.

Surgical removal of an adrenal tumor resolved hormonal issues in a young woman.

A man with a rare adrenal cancer showed unusual symptoms and died four months after diagnosis.

Targeted cancer therapies have a significant but lower risk of causing hair loss compared to chemotherapy.

Properly administered testosterone therapy is safe and effective but often not covered by insurance.

Upadacitinib significantly improved alopecia universalis and psoriatic arthritis in a patient.

5-α-reductase inhibitors reduce prostate cancer risk but may cause sexual dysfunction and don't affect high-grade tumor or death rates.

Some breast cancer patients treated with high-dose docetaxel may experience permanent hair loss.

Ritlecitinib may be more effective for severe alopecia areata than conventional treatments.

Using GnRHa agonists helps diagnose and treat ovarian hyperthecosis when surgery isn't possible.

Upadacitinib may effectively treat alopecia areata without side effects.